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Summary
Introduction: Histoplasmosis and penicilliosis are infections caused by the dimorphic
fungi, Histoplasma capsulatum and Penicillium marneffei, respectively. The aim of
this study was to compare the clinical presentation, laboratory and radiologic findings
and outcome of these infections at Srinagarind Hospital, Khon Kaen, Thailand.
Methods: The medical records of patients who had positive cultures for Histoplasma
capsulatum and Penicillium marneffei during 1996—2002 were reviewed. The data
were compared and analyzed by the Chi-square and Fisher’s exact tests.
Results: There were 32 and 36 medical records of patients with H. capsulatum and P.
marneffei infection, respectively, available for review. The most common underlying
disease of patients with histoplasmosis and penicilliosis was acquired immunodefi-
ciency syndrome (AIDS), which accounted for 90.6% and 91.7%, respectively. The most
common clinical findings in both infections were fever, weight loss, cough, anemia,
lymphadenopathy, hepatomegaly and splenomegaly. Frequencies of skin lesions were
not statistically different between either group (P = 0.20). Laboratory findings were
similar between the two infections, except hyperbilirubinemia, which was more
common in the penicilliosis group (P = 0.02). There were similar abnormal X-ray
findings in both groups with interstitial infiltration the most common abnormality.
Conclusions: Histoplasmosis and penicilliosis had similar clinical presentations,
laboratory findings and chest X-ray abnormalities. Itraconazole is recommended as
secondary prophylaxis in HIV-infected patients who have histoplasmosis or penicil-
liosis.
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Histoplasmosis and penicilliosis are infections
caused by the dimorphic fungi, Histoplasma capsu-
latum and Penicilliummarneffei, respectively. They
can cause clinical disease both in normal and immu-
nocompromised hosts, including those with
acquired immunodeficiency syndrome (AIDS), sys-
temic lupus erythematosus, corticosteroid or immu-
nosuppressive agent use.1—4
In Thailand, penicilliosis is more common than
histoplasmosis.5 According to the Ministry of Public
Health of Thailand, the cumulative number of AIDS
patients during 1984—2004 with penicilliosis was
6323 and with histoplasmosis was 631. Because
both fungi are yeast forms in stained clinical speci-
mens, they are difficult to differentiate. In fungal
culture media, H. capsulatum grows more slowly
than P. marneffei. This may explain the lower
incidence of histoplasmosis in Thailand, where
experienced personnel and good laboratory facil-
ities are lacking.
The objective of this study is to present the
authors’ experience of the initial presentations,
laboratory findings and outcome in patients with
histoplasmosis and penicilliosis. This may be helpful
for clinicians who are not familiar with either of
these fungi. This is also the first report comparing
both infections in the literature.Materials and methods
Setting
The Srinagarind Hospital is a 700-bed university
teaching hospital affiliated with Khon Kaen Univer-
sity, providing healthcare for a population of nearly
1,500,000 inhabitants. There are approximately
32,000 admissions and 490,000 visits to the out-
patient clinic each year.Table 1 Age, sex, and underlying diseases of patients with
Thailand 1996—2002.
Nu
His
Age in years (mean  SD) 32.
Sex (male:female) 3.
Underlying disease
Acquired immunodeficiency syndrome 29
Connective tissue disease 1
Diabetes mellitus 0
Nontuberculous mycobacterial disease 1
No underlying disease 1Study design
The medical records of patients with clinical evi-
dence of infection during 1996—2002 and who had a
positive culture of Histoplasma capsulatum or Peni-
cillium marneffei from a clinical specimen were
retrospectively reviewed. Patients who were less
than 15 years old were excluded. The epidemiolo-
gical data, clinical features, laboratory findings and
outcome were collected.
Microbiological methods
Blood samples were processed in the BacT/Alert
(Organon Teknika, Durham, NC, USA) continuous-
monitoring blood culture system. Cultures of clinical
specimens, such as sputum, lymph node tissue, and
bone marrow were performed on Sabouraud’s dex-
trose agar at 25 8C. Isolates that were visible within
two or three days of incubation were subcultured on
brain-heart infusion agar and incubated at 37 8C.
Positive cultures for P. marneffei and H. capsulatum
were characterised as dimorphic fungi that grew as a
mold at 25 8C and as a yeast at 37 8C. Methods of
identification and mycological characteristics of
these fungi are described elsewhere.2—3
Statistical analysis
Data were entered and analyzed with SPSS Profes-
sional Statistics, version11.0.Comparabilitybetween
the groups was assessed by analysis with Chi-square
and Fisher’s exact tests for categorical variables and
Student’s t test for continuous variables. P values
<0.05 were considered to be significant.Results
During the seven-year period, there were 34 and
36 patients who had positive cultures for H. cap-histoplasmosis and penicilliosis at Srinagarind Hospital,
mber of patients
toplasmosis (n = 32) Penicilliosis (n = 36)
9  6.8 34.4  9.7
6:1 4.1:1
33
1
1
1
0
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Table 2 Clinical features of patients with histoplasmosis and penicilliosis at Srinagarind Hospital, Thailand 1996—
2002.
Clinical features Number of patients (%) P value
Histoplasmosis (n = 32) Penicilliosis (n = 36)
Fever 31 (96.8) 34 (94.4) 0.62
Weight loss 27 (84.4) 32 (88.9) 0.58
Diarrhea 9 (28.1) 11 (30.5) 0.82
Abdominal pain 4 (12.5) 16 (44.4) 0.003
Cough 13 (40.6) 18 (50.0) 0.43
Bleeding 1 (3.1) 2 (5.5) 0.62
Hypotension (BP <90/60 mmHg) 12 (37.5) 3 (8.3) 0.01
Anemia 29 (90.6) 34 (94.4) 0.54
Jaundice 4 (12.5) 2 (5.5) 0.31
Lymphadenopathy 24 (75.0) 15 (41.7) 0.005
Hepatomegaly 21 (65.6) 25 (69.4) 0.49
Splenomegaly 12 (37.5) 20 (55.5) 0.13
Skin lesions 12 (37.5) 19 (52.8) 0.20
Plaques/papules 5 (15.6) 1 (2.8) 0.06
Umbilicated papules 4 (12.5) 13 (33.3) 0.02
Ulcers 2 (6.2) 1 (2.8) 0.48
Maculopapular rash 1 (2.8) 0 0.28
Vesicles 0 1 (2.8) 0.34
Pustules 0 1 (2.8) 0.34
Subcutaneous abscess 0 2 (5.6) 0.17sulatum and P. marneffei respectively, and 32 and
36 sets of medical records respectively, available
for data review. Age, sex, and underlying diseases
are detailed in Table 1. There was no mixed
infection of both fungi found in the study period.
However, there were four cases with concurrent
bacteremia (Streptococcus group B 1, Salmonella
1, Serratia 1, Enterobacter 1) and two with cryp-
tococcal meningitis in the histoplasmosis group.
There were two cases of Salmonella bacteremia
and three cases of cryptococcal meningitis in the
penicilliosis group.
The most common underlying disease was AIDS,
accounting for 90.6% and 91.7% of the underlying
disease in each group, respectively.Table 3 Laboratory findings of patients with histoplasmosis
2002.
Laboratory findings Numbe
Histop
Anemia (hemoglobin <10 g/dl) 21/30
Neutropenia (WBC <3  109/L) 8/30 (
Thrombocytopenia (platelets <100  109/L) 10/30
Pancytopenia 2/30 (
Hypercalcemia (Ca >10 g/dl) 0/17 (
Hypoalbuminemia (albumin <2.5 g/dl) 12/26
Hyperbilirubinemia (total bilirubin >2.0 g/dl) 3/27 (
SGPT elevation (>5 times UNL) 1/27 (
Alkaline phosphatase elevation (>3 times UNL) 14/27
UNL = upper normal limit.Clinical features are presented in Table 2. The
most common symptoms in both groups of patients
were fever, weight loss and cough. Abdominal pain
was more common in penicilliosis patients
(P < 0.05). The common physical findings in both
groups were anemia, lymphadenopathy, hepatome-
galy and splenomegaly. Hypotension and lymphade-
nopathy were more common in patients with
histoplasmosis than penicilliosis (P < 0.05). Skin
lesions were found equally in both penicilliosis
and histoplasmosis patients (P = 0.20). However,
umbilicated papules were more common in the
penicilliosis group (P < 0.05).
Laboratory findings in both infections are shown
in Table 3. Hematologic abnormalities were com-and penicilliosis at Srinagarind Hospital, Thailand 1996—
r of patients (%) P value
lasmosis (n = 32) Penicilliosis (n = 36)
(70.0) 29/35 (82.8) 0.22
20.7) 7/35 (20.0) 0.52
(33.3) 14/35 (40.0) 0.57
6.7) 6/35 (17.1) 0.19
0.0) 0/2 (0.0) —
(46.1) 21/30 (70.0) 0.47
11.1) 11/30 (36.7) 0.02
3.7) 1/30 (3.3) 0.94
(51.8) 18/29 (62.1) 0.44
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Table 4 Results of microscopic diagnosis and cultures of patients with histoplasmosis and penicilliosis at Srinagarind
Hospital, Thailand 1996—2002.
Number of patients (%)
Histoplasmosis (n = 32) Penicilliosis (n = 36)
Positive microscopic exam 32/32 (100.0) 36/36 (100.0)
Bone marrow 23/23 (100.0) 21/21 (100.0)
Sputum 5/12 (41.7) 5/10 (50.0)
Pleural fluid 0/1 (0.0) 0/3 (0.0)
Pus or skin scraping 12/12 (100.0) 18/19 (94.7)
Lymph node 13/13 (100.0) 7/7 (100.0)
Positive cultures 32/32 (100.0) 36/36 (100.0)
Blood 0/30 (0.0) 16/35 (45.7)
Bone marrow 23/23 (100.0) 19/21 (90.4)
Sputum 0/12 (0.0) 1/10 (10.0)
Pleural fluid 0/1 (0.0) 2/3 (67.7)
Pus or skin scraping 2/2 (100.0) 8/9 (88.9)
Lymph node 3/13 (23.1) 7/7 (100.0)mon. Hyperbilirubinemia was more common in the
penicilliosis group than in the histoplasmosis group
(P < 0.05).
Table 4 shows the results of microscopic exam-
ination and cultures of specimens. Bone marrow
fluid culture was positive in all histoplasmosis
patients and 90.4% of penicilliosis patients. Hemo-
culture was negative in all histoplasmosis patients
but positive in 50% of penicilliosis patients.
Table 5 demonstrates radiographic findings in
both groups. There were no differences in abnorm-
alities seen on chest X-rays in either group
(P = 0.38).
There were 30 cases of histoplasmosis and 34
cases of penicilliosis admitted to the hospital that
were given amphotericin B intravenously at a dose
of 0.7 mg/kg/day. Three cases with histoplasmosis
and five cases with penicilliosis died in the hospital,
accounting for in-hospital mortality of 10% and
14.7%, respectively. The other 27 cases of histoplas-
mosis and 29 cases of penicillosis were discharged
from the hospital and received oral itraconazoleTable 5 Chest X-ray findings of patients with histoplasmosis
2002.
Chest X-ray findings Num
His
Normal 19
Abnormal 13
Alveolar/patchy infiltration 2
Interstitial infiltration 7
Mixed alveolar/interstitial infiltration 0
Miliary infiltration 2
Pleural effusion 1
Cavitation 1400 mg/day as maintenance therapy initially for
three months then 200 mg/day afterwards. The
median duration of follow up for patients with
histoplasmosis was longer than the follow up of
patients with penicilliosis, (9.5 months (range
0.5—40 months) versus 22 months (range 1—75
months)) respectively (P < 0.05). No patient had a
relapse on itraconazole maintenance therapy.
Discussion
Histoplasmosis and penicilliosis are serious oppor-
tunistic fungal infections in AIDS patients. Histoplas-
mosis is endemic in certain parts of the world, such
as the USA and South America, but there are only a
few reports of histoplasmosis in Thailand despite the
AIDS epidemic.6—8 However, penicilliosis is common
in Thailand as well as in other southeast Asian coun-
tries such as China and Vietnam, and is therefore
considered an endemic mycosis of this region.3—5
Because most of the Thai patients with histoplas-and penicilliosis at Srinagarind Hospital, Thailand 1996—
ber of patients (%)
toplasmosis (n = 32) Penicilliosis (n = 36)
(59.4) 25 (78.1)
(40.6) 11 (21.9)
(6.2) 2 (6.2)
(21.9) 5 (15.6)
(0.0) 1 (3.1)
(6.2) 1 (3.1)
(3.1) 3 (9.4)
(3.1) 1 (3.1)
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mentioned above, Histoplasma capsulatum may
also be endemic to this region.
Reports from before the AIDS era revealed that
histoplasmosis and penicilliosis could occur in
both immunocompetent and immunocompromised
patients and presented as prolonged fever, muco-
cutaneous ulcers or pneumonia.1,3 In this study, all
but one of the patients had underlying diseases,
mostly HIV infection (Table 1). Almost all patients
had dissemination but one patient with systemic
lupus erythematosus had localized skin infection
with histoplasmosis.
In this study, most of the clinical presentations of
the histoplasmosis group were the same as those of
the penicilliosis group (Table 1). However, abdom-
inal pain was more common in the latter whereas
hypotension and lymphadenopathy were more com-
mon in the former. Adrenal gland involvement was
occasionally reported in histoplasmosis1,9,10 and
might have caused hypotension in some of the
reported cases.
Skin lesions in the histoplasmosis group were less
common than in the penicilliosis group (37.5% versus
52.8%) but not statistically different (Table 2).Wheat
et al.2 reported skin lesions in only 1.4% of AIDS cases
with histoplasmosis, whereas Cohen et al.11 reported
a figure of 10.8%. Supparatpinyo et al.4 reported that
71% of P. marneffei cases in AIDS patients had skin
lesions, of which 87% were umbilicated papules. In
this study erythematous plaques were most com-
monly found in the histoplasmosis group (15.6%)
whereas umbilicated papules were more common
in penicilliosis (33.3%). However, no single type of
skin lesion is pathognomonic for either infection.
Most laboratory findings were similar for both
infections except hyperbilirubinemia, which was
more common in the penicilliosis group (Table 3).
All cases had an initial diagnosis by positive stain-
ing of discharge or by bone marrow examination
before the positive culture results (Table 4). This
reflects high fungal burden due to severe immuno-
suppression due to underlying diseases or their
treatments. The characteristic morphology of His-
toplasma capsulatum is oval or round budding yeasts
intracellularly and extracellularly, differing from
Penicillium marneffei, which are sausage-shaped
yeasts with a central clear septum, resembling cells
undergoing binary fission. As the organisms may
cluster and be overcrowded in tissues it may not
be possible to differentiate them correctly by mor-
phology alone. In addition, Histoplasma capsulatum
and Penicillium marneffei infections can occur as
mixed infections together or with Cryptococcus
neoformans,12 and therefore require culture to con-
firm the diagnosis. Hemocultures were not helpful inhistoplasmosis by contrast with those of penicillio-
sis, which were positive in half the patients in this
study (Table 4). The characteristics of colonies of
Histoplasma capsulatum in fungal media may also
be used for rapid differentiation from those of
Penicilliummarneffei because the former are white
while the latter are red.
In this series, abnormal chest X-ray findings were
more common in the histoplasmosis group (Table 5).
Interstitial infiltration was the most common find-
ing. Cohen et al.11 reported that 81% of HIV-infected
patients with disseminated histoplasmosis and skin
lesions had an abnormal chest X-ray.
The recommended therapy of both fungi is the
same: amphotericin B 0.7 mg/kg/day for two
weeks, followed by itraconazole 400 mg/day for
at least 10—12 weeks. Because of frequent relapses
of these fungal infections in HIV-infected patients,
lifelong maintenance of itraconazole of at least
200 mg/day is recommended.13—15
The prognosis of both fungal infections in this
study was good. In-hospital mortality in the histo-
plasmosis group was the same as that of the peni-
cilliosis group (10% versus 14.7%, P = 0.56). No
relapse of either infection occurred during long-
term itraconazole therapy in HIV-infected patients.
This result supports the need for secondary prophy-
laxis of these infections in HIV-infected patients.
In conclusion, histoplasmosis and penicilliosis had
similar clinical presentations, laboratory findings
and chest X-ray abnormalities, although some fea-
tures may be more common than others. Response
to treatment was good with low in-hospital mortal-
ity. No relapse occurred in the HIV-infected patients
who had itraconazole as long-term therapy. There-
fore, itraconazole is recommended as secondary
prophylaxis in HIV-infected patients who have his-
toplasmosis or penicilliosis.
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